Sign In
test

Erin O'Connor

Fairmount Funds Management Llc

Assets Managed
$1.384B
Holdings
12
Last Quarter
2026 - Q1
Filed Date
1mo 5d ago
Growth Rate
5.38%(2Q avg: 11.79%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Fairmount Funds Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 12 positions.

Assets under management

The assets under management (AUM) of Fairmount Funds Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.384B in assets, with a quarterly growth rate of 5.38% and a 2-quarter average growth rate of 11.79%. The portfolio is managed by Erin O'Connor, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
GLTO
Galecto Inc
Recent Activity
New Position
16.31%
$225.667M
8.713M shares@ $25.9 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Increased 18.72%
15.39%
$212.921M
2.537M shares@ $83.93 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Decreased -38.87%
15.31%
$211.827M
5.503M shares@ $38.5 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
14.65%
$202.673M
4.018M shares@ $50.44 avg price
ORKA
Oruka Therapeutics Inc
Recent Activity
13.13%
$181.743M
3.705M shares@ $49.05 avg price
VRDN
Viridian Therapeutics Inc
Recent Activity
5.54%
$76.567M
3.914M shares@ $19.56 avg price
ELVN
Enliven Therapeutics Inc
Recent Activity
Decreased -50%
5.26%
$72.741M
1.856M shares@ $39.21 avg price
JBIO
Jade Biosciences Inc
Recent Activity
4.63%
$63.977M
4.553M shares@ $14.06 avg price
CBIO
Crescent Biopharma Inc
Recent Activity
3.65%
$50.478M
2.748M shares@ $18.37 avg price
ZBIO
Zenas Biopharma Inc
Recent Activity
Increased 6.8%
3.34%
$46.119M
2.359M shares@ $19.56 avg price

1-10 of 12